Heart plug tested to shield dialysis patients from strokes
NCT ID NCT07257614
Summary
This pilot study is testing a small heart implant, called a left atrial appendage occlusion (LAAO), in patients who have both kidney failure requiring dialysis and atrial fibrillation (AF). The goal is to see if this device is a safe and effective way to prevent strokes and major bleeding events in this high-risk group, potentially offering an alternative to blood thinners. The study will enroll 40 patients to receive the implant and compare their outcomes to a matched group from past records.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Chinese Universityy of Hong Kong
Shatin, New Territories, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.